Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krasinski

Showing results (261-270 of 275) with videos related to

Pageof 28
Sort By:
Plos One|April 20, 2022
Late date of human arrival to North America: Continental scale differences in stratigraphic integrity of pre-13,000 BP archaeological sitesTodd A Surovell, Sarah A Allaun, Barbara A Crass, et al.
Plos One|July 24, 2024
Correction: Late date of human arrival to North America: Continental scale differences in stratigraphic integrity of pre-13,000 BP archaeological sitesTodd A Surovell, Sarah A Allaun, Barbara A Crass, et al.
Metabolism: Clinical and Experimental|August 20, 2013
Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetesTimothy J Sullivan, Zhenhua Miao, Bin N Zhao, et al.
Plos One|March 22, 2018
CCR2 antagonism leads to marked reduction in proteinuria and glomerular injury in murine models of focal segmental glomerulosclerosis (FSGS)Zhenhua Miao, Linda S Ertl, Dale Newland, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 3, 2019
CCR2-Mediated Uptake of Constitutively Produced CCL2: A Mechanism for Regulating Chemokine Levels in the BloodBin N Zhao, James J Campbell, Catherina L Salanga, et al.
Nature Communications|September 1, 2011
Blimp1 regulates the transition of neonatal to adult intestinal epitheliumVanesa Muncan, Jarom Heijmans, Stephen D Krasinski, et al.
American Journal of Physiology. Renal Physiology|August 30, 2013
CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin miceTimothy Sullivan, Zhenhua Miao, Daniel J Dairaghi, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 2, 2012
Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complicationsTimothy J Sullivan, Daniel J Dairaghi, Antoni Krasinski, et al.
Science Advances|January 17, 2024
A female woolly mammoth's lifetime movements end in an ancient Alaskan hunter-gatherer campAudrey G Rowe, Clement P Bataille, Sina Baleka, et al.
Chest|October 11, 2025
Post-Intensive Care Syndrome Awareness and Communication: Surveys of ICU Providers and PatientsMark L Rolfsen, Matthew F Mart, Hannah Kieffer, et al.
Pageof 28

Showing results (261-270 of 275) with videos related to

Sort By:
Pageof 28
Plos One|April 20, 2022
Late date of human arrival to North America: Continental scale differences in stratigraphic integrity of pre-13,000 BP archaeological sitesTodd A Surovell, Sarah A Allaun, Barbara A Crass, et al.
Plos One|July 24, 2024
Correction: Late date of human arrival to North America: Continental scale differences in stratigraphic integrity of pre-13,000 BP archaeological sitesTodd A Surovell, Sarah A Allaun, Barbara A Crass, et al.
Metabolism: Clinical and Experimental|August 20, 2013
Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetesTimothy J Sullivan, Zhenhua Miao, Bin N Zhao, et al.
Plos One|March 22, 2018
CCR2 antagonism leads to marked reduction in proteinuria and glomerular injury in murine models of focal segmental glomerulosclerosis (FSGS)Zhenhua Miao, Linda S Ertl, Dale Newland, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 3, 2019
CCR2-Mediated Uptake of Constitutively Produced CCL2: A Mechanism for Regulating Chemokine Levels in the BloodBin N Zhao, James J Campbell, Catherina L Salanga, et al.
Nature Communications|September 1, 2011
Blimp1 regulates the transition of neonatal to adult intestinal epitheliumVanesa Muncan, Jarom Heijmans, Stephen D Krasinski, et al.
American Journal of Physiology. Renal Physiology|August 30, 2013
CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin miceTimothy Sullivan, Zhenhua Miao, Daniel J Dairaghi, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 2, 2012
Characterization of CCX140-B, an orally bioavailable antagonist of the CCR2 chemokine receptor, for the treatment of type 2 diabetes and associated complicationsTimothy J Sullivan, Daniel J Dairaghi, Antoni Krasinski, et al.
Science Advances|January 17, 2024
A female woolly mammoth's lifetime movements end in an ancient Alaskan hunter-gatherer campAudrey G Rowe, Clement P Bataille, Sina Baleka, et al.
Chest|October 11, 2025
Post-Intensive Care Syndrome Awareness and Communication: Surveys of ICU Providers and PatientsMark L Rolfsen, Matthew F Mart, Hannah Kieffer, et al.
Pageof 28